These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 14125017)

  • 1. VASOCONSTRICTION AND VASODILATATION IN SHOCK.
    NICKERSON M
    Int Anesthesiol Clin; 1964 Feb; 2():385-97. PubMed ID: 14125017
    [No Abstract]   [Full Text] [Related]  

  • 2. THE NATURE OF EXPERIMENTAL IRREVERSIBLE SHOCK WITH ITS CLINICAL APPLICATION.
    LILLEHEI RC; LONGERBEAM JK; BLOCH JH; MANAX WG
    Int Anesthesiol Clin; 1964 Feb; 2():297-363. PubMed ID: 14125015
    [No Abstract]   [Full Text] [Related]  

  • 3. THE MANAGEMENT OF EXPERIMENTAL ENDOTOXIN SHOCK. THE CIRCULATORY EFFECTS OF LEVARTERENOL, HYDROCORTISONE, PHENOXYBENZAMINE HYDROCHLORIDE, AND BLOOD VOLUME EXPANSION.
    SMITH LL; MULLER W; HINSHAW DB
    Arch Surg; 1964 Oct; 89():630-6. PubMed ID: 14186793
    [No Abstract]   [Full Text] [Related]  

  • 4. VASODILATOR THERAPY IN ACUTE HEMORRHAGIC SHOCK.
    VICK JA; CIUCHTA HP; MERICKEL JH; LINDSETH EO
    Circ Res; 1965 Jan; 16():58-64. PubMed ID: 14252156
    [No Abstract]   [Full Text] [Related]  

  • 5. CARDIAC DETERIORATION IN SHOCK. II. THE IRREVERSIBLE STAGE.
    CROWELL JW; GUYTON AC
    Int Anesthesiol Clin; 1964 Feb; 2():171-84. PubMed ID: 14125007
    [No Abstract]   [Full Text] [Related]  

  • 6. The pathogenesis and management of peripheral circulatory failure.
    Dornhorst AC
    Ann R Coll Surg Engl; 1970 Mar; 46(3):172-5. PubMed ID: 5445661
    [No Abstract]   [Full Text] [Related]  

  • 7. Phenoxybenzamine-induced vasodilation: a stimulus to increased plasma volume with reduced central venous pressure and aldosterone hypersecretion in man.
    Skillman JJ; Eltringham WK; Zollinger RM; Lauler DP; Moore FD
    Surgery; 1968 Aug; 64(2):368-80. PubMed ID: 5673048
    [No Abstract]   [Full Text] [Related]  

  • 8. HEMODYNAMIC ACTION OF VASOPRESSOR AND VASODEPRESSOR AGENTS IN ENDOTOXIN SHOCK.
    MORRIS JA; SMITH RW; ASSALI NS
    Am J Obstet Gynecol; 1965 Feb; 91():491-503. PubMed ID: 14259138
    [No Abstract]   [Full Text] [Related]  

  • 9. CIRCULATORY RESPONSE TO LOW VISCOSITY DEXTRAN IN CLINICAL SHOCK.
    CAREY JS; WOODWARD NW; MOHR PA; SUZUKI F; BROWN RS; BAKER RJ; SHOEMAKER WC
    Surg Gynecol Obstet; 1965 Sep; 121():563-70. PubMed ID: 14332894
    [No Abstract]   [Full Text] [Related]  

  • 10. EVALUATION OF RED CELL EQUILIBRATION IN HEMORRHAGIC SHOCK.
    BAKER RJ; STVILLE JM; SUZUKI F; SHOEMAKER WC
    Arch Surg; 1965 Apr; 90():538-44. PubMed ID: 14267654
    [No Abstract]   [Full Text] [Related]  

  • 11. SEPTIC SHOCK.
    FRANK ED
    Int Anesthesiol Clin; 1964 Feb; 2():287-96. PubMed ID: 14125014
    [No Abstract]   [Full Text] [Related]  

  • 12. Canine cerebral blood flow following hemorrhage. Effect of dextran, dibenzyline and blood replacement.
    Rittmann WW; Smith LL
    Am Surg; 1966 Oct; 32(10):695-9. PubMed ID: 5921433
    [No Abstract]   [Full Text] [Related]  

  • 13. RENAL AND SYSTEMIC HEMODYNAMIC EFFECTS OF DIBENZYLINE IN NORMOTENSION AND HEMORRHAGIC HYPOTENSION.
    MURPHY GP; GAGNON JA; EWALD RA
    Surgery; 1965 Jun; 57():856-67. PubMed ID: 14297966
    [No Abstract]   [Full Text] [Related]  

  • 14. DIFFERENTIAL EFFECTS OF HEAT ON THE SPLENIC AND RENAL VASCULAR BEDS: VASOCONSTRICTION IN THE SPLEEN AND VASODILATION IN THE KIDNEY. REP 579.
    GILLENWATER JY; FROHLICH ED; KELLER AD
    Rep US Army Med Res Lab; 1963 Jun; ():1-10. PubMed ID: 14131241
    [No Abstract]   [Full Text] [Related]  

  • 15. LOW MOLECULAR WEIGHT DEXTRAN THERAPY IN SURGICAL SHOCK. 1. CONTROL GROUP AND SHOCK PATIENTS RESUSCITATED PRIOR TO LOW MOLECULAR WEIGHT DEXTRAN THERAPY.
    BAKER RJ; SHOEMAKER WC; SUZUKI F; FREEARK RJ; STROHL EL
    Arch Surg; 1964 Aug; 89():373-89. PubMed ID: 14162957
    [No Abstract]   [Full Text] [Related]  

  • 16. THE EFFECT OF DIBENZYLINE AND HYPERTENSIN ON SALURETIC PRESSOR AND "VOLUME" REFLEXES.
    CORT JH; LICHARDUS B
    Physiol Bohemoslov (1956); 1963; 12():304-9. PubMed ID: 14060616
    [No Abstract]   [Full Text] [Related]  

  • 17. Treatment of experimental shock: comparison of the effects of norepinephrine, dibenzyline, dextran, whole blood, and balanced saline solutions.
    Rush BF
    Surgery; 1967 Jun; 61(6):938-44. PubMed ID: 6026142
    [No Abstract]   [Full Text] [Related]  

  • 18. THE COMPARATIVE EFFECTS OF BLOOD, SALINE, AND LOW MOLECULAR DEXTRAN ON IRREVERSIBLE HEMORRHAGIC SHOCK.
    MCPHERSON RC; HALLER JA
    J Trauma; 1964 Jul; 4():415-23. PubMed ID: 14178835
    [No Abstract]   [Full Text] [Related]  

  • 19. TREATMENT OF EXPERIMENTAL CARDIOGENIC SHOCK.
    BLOCH JH; PIERCE CH; MANAX WG; LILLEHEI RC
    Surgery; 1965 Jul; 58():197-214. PubMed ID: 14305154
    [No Abstract]   [Full Text] [Related]  

  • 20. EXPERIMENTAL HEMORRHAGE IN LATE PREGNANCY. EFFECTS ON MATERNAL AND FETAL HEMODYNAMICS.
    ROMNEY SL; GABEL PV; TAKEDA Y
    Am J Obstet Gynecol; 1963 Nov; 87():636-49. PubMed ID: 14074029
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.